Besides, the targets mentioned in this study, such as kappa-type opioid receptor (KOR), orexin type 2 receptor (OX2R), and N-methyl-D-aspartate receptor (NMDAR) and so on, may also become new mechanisms for treating psychiatric disorders (52–54). This evidence concerns the gene OPRK1 and psychiatric disorder.